CardioFocus: Funding, Investors & Team (Sep 2026)
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders. The company specializes in providing electrophysiologists with innovative and effective tools that bring new levels of precision and control to the treatment of atrial fibrillation that focuses on developing, manufacturing, and investigating disposable fiber optic catheters for the visualization of the cardiac anatomy and the treatment of cardiac arrhythmias. CardioFocus was founded in 1990 and is headquartered in Marlborough, Massachusetts.
CardioFocus has raised $4.0M across 1 funding round on record, the most recent an undisclosed round of $4.0M announced in Apr 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CardioFocus Company Profile and Key Stats
Latest funding round on record: Apr 2022.
CardioFocus Funding Rounds
CardioFocus Founders and Leadership Team
No contact details are on record for this team yet.
CardioFocus Funding Compared to Other Biotechnology Startups
CardioFocus' latest round of $4.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CardioFocus in Biotechnology and Marlborough
Companies Similar to CardioFocus
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
CardioFocus Funding FAQs
What does CardioFocus do?
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders. The company specializes in providing electrophysiologists with innovative and effective tools that bring new levels of precision and control to the treatment of atrial fibrillation that focuses on developing, manufacturing, and investigating disposable fiber optic catheters for the visualization of the cardiac anatomy and the treatment of cardiac arrhythmias. CardioFocus was founded in 1990 and is headquartered in Marlborough, Massachusetts.
How much funding has CardioFocus raised?
CardioFocus has raised $4.0M across 1 round on record. The most recent is an undisclosed round of $4.0M announced in Apr 2022.
When did CardioFocus last raise funding?
CardioFocus' most recent funding round on record is an undisclosed round of $4.0M, announced in Apr 2022.
Who is the CEO of CardioFocus?
Burke Barrett is listed as CEO at CardioFocus.
Where is CardioFocus headquartered?
CardioFocus is based in Marlborough, Massachusetts, United States.
How many employees does CardioFocus have?
CardioFocus is in the 51-100 employee band.
How does CardioFocus' funding compare to other Biotechnology startups?
CardioFocus' latest round of $4.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's CardioFocus Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CardioFocus is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.